The importance of regulating p53 aggregation properties has been highlighted by a recent study showing that aggregation of structurally destabilized cancer mutants is responsible for oncogenic gain of function through co-aggregation with the p53 family members p63 and p73.31 This evidence concerns the gene TP53 and cancer.